After four years of anatomy, rounds and rotations – and many late-night study sessions – the first class from Nova Southeastern University’s College of Allopathic Medicine is graduating on Friday.
Phase II study of pevonedistat (P) + azacitidine (A) versus A in patients (pts) with higher-risk myelodysplastic syndromes (MDS)/chronic myelomonocytic leukemia (CMML), or low-blast acute myelogenous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results